Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 364738, 7 pages
http://dx.doi.org/10.1155/2014/364738
Review Article

Circulating Endothelial Cells and Chronic Kidney Disease

Department of Nephrology, Weifang People’s Hospital, No. 151 Guangwen Street, Kuiwen District, Weifang, Shandong 261041, China

Received 28 February 2014; Revised 30 April 2014; Accepted 3 May 2014; Published 18 May 2014

Academic Editor: Keiju Hiromura

Copyright © 2014 Kunying Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” The New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. K. Cheung, M. J. Sarnak, G. Yan et al., “Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients,” Kidney International, vol. 58, no. 1, pp. 353–362, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. P. S. Parfrey, “Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management,” Nephrology Dialysis Transplantation, vol. 15, no. 5, pp. 58–68, 2000. View at Google Scholar · View at Scopus
  4. E. Ritz and W. M. McClellan, “Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences,” Journal of the American Society of Nephrology, vol. 15, no. 3, pp. 513–516, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Tabas, A. Tall, and D. Accili, “The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression,” Circulation Research, vol. 106, no. 1, pp. 58–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. S. Celermajer, K. E. Sorensen, V. M. Gooch et al., “Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis,” The Lancet, vol. 340, no. 8828, pp. 1111–1115, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. E. L. Schiffrin, H. D. Intengan, G. Thibault, and R. M. Touyz, “Clinical significance of endothelin in cardiovascular disease,” Current Opinion in Cardiology, vol. 12, pp. 354–367, 1997. View at Google Scholar
  10. B. Feldt-Rasmussen, “Microalbuminuria, endothelial dysfunction and cardiovascular risk,” Diabetes and Metabolism, vol. 26, supplement 4, pp. 64–66, 2000. View at Google Scholar · View at Scopus
  11. R. A. Preston, M. Ledford, B. J. Materson, N. M. Baltodano, A. Memon, and A. Alonso, “Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand Factor,” Journal of Hypertension, vol. 20, no. 5, pp. 871–877, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Solovey, Y. Lin, P. Browne, S. Choong, E. Wayner, and R. P. Hebbel, “Circulating activated endothelial cells in sickle cell anemia,” The New England Journal of Medicine, vol. 337, pp. 1584–1590, 1997. View at Google Scholar
  13. A. Woywodt, F. Streiber, K. De Groot, H. Regelsberger, H. Haller, and M. Haubitz, “Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis,” The Lancet, vol. 361, no. 9353, pp. 206–210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Woywodt, M. Schroeder, M. Mengel et al., “Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage,” Hypertension, vol. 41, no. 3, pp. 720–723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Koç, A. Bihorac, and M. S. Segal, “Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients,” The American Journal of Kidney Diseases, vol. 42, no. 4, pp. 704–712, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. H. G. Augustin, D. H. Kozian, and R. C. Johnson, “Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes,” BioEssays, vol. 16, no. 12, pp. 901–906, 1994. View at Google Scholar · View at Scopus
  17. K. Caglar, M. I. Yilmaz, M. Saglam et al., “Serum fetuin-A concentration and endothelial dysfunction in chronic kidney disease,” Nephron—Clinical Practice, vol. 108, no. 3, pp. c233–c240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Merino, S. Nogueras, P. Buendía et al., “Microinflammation and endothelial damage in hemodialysis,” Contributions to Nephrology, vol. 161, pp. 83–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. U. Schwarz, M. Buzello, E. Ritz et al., “Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure,” Nephrology Dialysis Transplantation, vol. 15, no. 2, pp. 218–223, 2000. View at Google Scholar · View at Scopus
  20. B. Xu, R. Chibber, D. Ruggerio, E. Kohner, J. Ritter, and A. Ferro, “Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products,” The FASEB Journal, vol. 17, no. 10, pp. 1289–1291, 2003. View at Google Scholar · View at Scopus
  21. V. Faure, L. Dou, F. Sabatier et al., “Elevation of circulating endothelial microparticles in patients with chronic renal failure,” Journal of Thrombosis and Haemostasis, vol. 4, no. 3, pp. 566–573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. B. K. I. Meijers, S. Van kerckhoven, K. Verbeke et al., “The uremic retention solute p-cresyl sulfate and markers of endothelial damage,” The American Journal of Kidney Diseases, vol. 54, no. 5, pp. 891–901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Masai, J. Tatebe, G. Yoshino, and T. Morita, “Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-κB pathway,” Circulation Journal, vol. 74, no. 10, pp. 2216–2224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Tumur, H. Shimizu, A. Enomoto, H. Miyazaki, and T. Niwa, “Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-κB activation,” The American Journal of Nephrology, vol. 31, no. 5, pp. 435–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Brunet, B. Gondouin, A. Duval-Sabatier et al., “Does uremia cause vascular dysfunction?” Kidney and Blood Pressure Research, vol. 34, no. 4, pp. 284–290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Mallamaci, G. Tripepi, S. Cutrupi, L. S. Malatino, and C. Zoccali, “Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD,” Kidney International, vol. 67, no. 6, pp. 2330–2337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Yao, M. Jumabay, A. Ly, M. Radparvar, M. R. Cubberly, and K. I. Bostrom, “A role for the endothelium in vascular calcification,” Circulation Research, vol. 113, pp. 495–504, 2013. View at Google Scholar
  28. G. M. London, A. P. Guérin, S. J. Marchais, F. Métivier, B. Pannier, and H. Adda, “Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality,” Nephrology Dialysis Transplantation, vol. 18, no. 9, pp. 1731–1740, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. L. Sutliff, E. R. Walp, A. M. El-Ali, S. Elkhatib, K. A. Lomashvili, and W. C. O'Neill, “Effect of medial calcification on vascular function in uremia,” The American Journal of Physiology—Renal Physiology, vol. 301, no. 1, pp. F78–F83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. D. Blann, A. Woywodt, F. Bertolini et al., “Circulating endothelial cells. Biomarker of vascular disease,” Thrombosis and Haemostasis, vol. 93, no. 2, pp. 228–235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Lin, D. J. Weisdorf, A. Solovey, and R. P. Hebbel, “Origins of circulating endothelial cells and endothelial outgrowth from blood,” Journal of Clinical Investigation, vol. 105, no. 1, pp. 71–77, 2000. View at Google Scholar · View at Scopus
  32. C. Bouvier, E. Gaynor, J. Cintron, B. Bernhardt, and T. Spaet, “Circulating endothelium as an indicator of vascular injury,” Thrombosis et Diathesis Haemorrhagica, vol. 40, supplement, pp. 163–168, 1970. View at Google Scholar
  33. J. Hladovec, I. Prerovsky, V. Stanek, and J. Fabian, “Circulating endothelial cells in acute myocardial infarction and angina pectoris,” Klinische Wochenschrift, vol. 56, no. 20, pp. 1033–1036, 1978. View at Google Scholar · View at Scopus
  34. Y. Iwata, F. Kuzuya, and M. Hayakawa, “Circulating endothelial cells fail to induce cerebral infarction in rabbits,” Stroke, vol. 17, no. 3, pp. 506–509, 1986. View at Google Scholar · View at Scopus
  35. J. Hladovec and I. Prerovský, “Endothelial lesion in hypertension,” Cor et Vasa, vol. 31, no. 1, pp. 51–54, 1989. View at Google Scholar · View at Scopus
  36. B. E. P. B. Ballieux, P. S. Hiemstra, N. Klar-Mohamad et al., “Detachment and cytolysis of human endothelial cells by proteinase 3,” European Journal of Immunology, vol. 24, no. 12, pp. 3211–3215, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. P. L. Van Haelst, A. C. M. Kobold, J. J. Van Doormaal, and J. W. C. Tervaert, “AECA and ANCA in patients with premature atherosclerosis,” International Reviews of Immunology, vol. 21, no. 1, pp. 19–26, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. K. S. Heo, E. Chang, N. T. Le et al., “De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis,” Circulation Research, vol. 112, pp. 911–923, 2013. View at Google Scholar
  39. A. Woywodt, F. H. Bahlmann, K. De Groot, H. Haller, and M. Haubitz, “Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer,” Nephrology Dialysis Transplantation, vol. 17, no. 10, pp. 1728–1730, 2002. View at Google Scholar · View at Scopus
  40. C. Holmén, E. Elsheikh, P. Stenvinkel et al., “Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement,” Journal of the American Society of Nephrology, vol. 16, no. 10, pp. 3110–3120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Hobson and J. Denekamp, “Endothelial proliferation in tumours and normal tissues: continuous labelling studies,” British Journal of Cancer, vol. 49, no. 4, pp. 405–413, 1984. View at Google Scholar · View at Scopus
  42. B. A. Caplan and C. J. Schwartz, “Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta,” Atherosclerosis, vol. 17, no. 3, pp. 401–417, 1973. View at Google Scholar · View at Scopus
  43. L. Bonello, A. Basire, F. Sabatier, F. Paganelli, and F. Digant-George, “Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease,” Journal of Thrombosis and Haemostasis, vol. 4, no. 5, pp. 979–981, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. U. Erdbruegger, M. Haubitz, and A. Woywodt, “Circulating endothelial cells: a novel marker of endothelial damage,” Clinica Chimica Acta, vol. 373, no. 1-2, pp. 17–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. S. S. Khan, M. A. Solomon, and J. P. McCoy Jr., “Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry,” Cytometry Part B—Clinical Cytometry, vol. 64, no. 1, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. S. Segal, A. Bihorac, and M. Koç, “Circulating endothelial cells: tea leaves for renal disease,” The American Journal of Physiology—Renal Physiology, vol. 283, no. 1, pp. F11–F19, 2002. View at Google Scholar · View at Scopus
  47. N. Bardin, F. Anfosso, J. Massé et al., “Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion,” Blood, vol. 98, no. 13, pp. 3677–3684, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Anfosso, N. Bardin, E. Vivier, F. Sabatier, J. Sampol, and F. Dignat-George, “Outside-in signaling pathway linked to CD146 engagement in human endothelial cells,” Journal of Biological Chemistry, vol. 276, no. 2, pp. 1564–1569, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. M. F. Elshal, S. S. Khan, Y. Takahashi, M. A. Solomon, and J. P. McCoy Jr., “CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood,” Blood, vol. 106, no. 8, pp. 2923–2924, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Sorrentino, M. Ferracin, G. Castelli et al., “Isolation and characterization of CD146+ multipotent mesenchymal stromal cells,” Experimental Hematology, vol. 36, no. 8, pp. 1035–1046, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Woywodt, A. D. Blann, T. Kirsch et al., “Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol,” Journal of Thrombosis and Haemostasis, vol. 4, no. 3, pp. 671–677, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Kraan, M. H. Strijbos, A. M. Sieuwerts et al., “A new approach for rapid and reliable enumeration of circulating endothelial cells in patients,” Journal of Thrombosis and Haemostasis, vol. 10, no. 5, pp. 931–939, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Mariucci, B. Rovati, S. Chatzileontiadou et al., “A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 69, no. 3, pp. 433–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Ozdogu, O. Sozer, C. Boga, I. Kozanoglu, E. Maytalman, and M. Guzey, “Flow cytometric evaluation of circulating endothelial cells: a new protocol for identifying endothelial cells at several stages of differentiation,” The American Journal of Hematology, vol. 82, no. 8, pp. 706–711, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. F. George, C. Brisson, P. Poncelet et al., “Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to Immuno-Magnetic beads: demonstration of endothelial injury after angioplasty,” Thrombosis and Haemostasis, vol. 67, no. 1, pp. 147–153, 1992. View at Google Scholar · View at Scopus
  56. G. Moroni, N. Del Papa, L. M. Moronetti et al., “Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease,” Kidney International, vol. 68, no. 2, pp. 562–568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Del Papa, G. Colombo, N. Fracchiolla et al., “Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis,” Arthritis and Rheumatism, vol. 50, no. 4, pp. 1296–1304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Jacques, N. Vimond, R. Conforti et al., “Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay,” Journal of Immunological Methods, vol. 337, no. 2, pp. 132–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Woywodt, T. Kirsch, and M. Haubitz, “Immunomagnetic isolation and FACS—competing techniques for the enumeration of circulating endothelial cells,” Thrombosis and Haemostasis, vol. 96, no. 1, pp. 1–2, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. S. C. Lim, A. E. Caballero, P. Smakowski, F. W. LoGerfo, E. S. Horton, and A. Veves, “Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria,” Diabetes Care, vol. 22, no. 11, pp. 1865–1870, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Woywodt, M. Schroeder, W. Gwinner et al., “Elevated numbers of circulating endothelial cells in renal transplant recipients,” Transplantation, vol. 76, no. 1, pp. 1–4, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. A. J. Makin, A. D. Blann, N. A. Y. Chung, S. H. Silverman, and G. Y. H. Lip, “Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells: relationship with von Willebrand factor and tissue factor,” European Heart Journal, vol. 25, no. 5, pp. 371–376, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. K. W. Lee, A. D. Blann, and G. Y. H. Lip, “Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes,” International Journal of Cardiology, vol. 111, no. 2, pp. 302–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. H. Strijbos, P. P. Landburg, E. Nur et al., “Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia?” Blood Cells, Molecules, and Diseases, vol. 43, no. 1, pp. 63–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. M. M. Grefte, M. Van der Giessen, W. Van Son, and T. H. The, “Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection,” Journal of Infectious Diseases, vol. 167, no. 2, pp. 270–277, 1993. View at Google Scholar · View at Scopus
  66. R. Clancy, G. Marder, V. Martin, H. M. Belmont, S. B. Abramson, and J. Buyon, “Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy,” Arthritis & Rheumatology, vol. 44, pp. 1203–1208, 2001. View at Google Scholar
  67. L. Camoin-Jau, I. Kone-Paut, B. Chabrol, J. Sampol, and F. Dignat-George, “Circulating endothelial cells in Behcet's disease with cerebral thrombophlebitis,” Thrombosis and Haemostasis, vol. 83, no. 4, pp. 631–632, 2000. View at Google Scholar · View at Scopus
  68. K. W. Lee, G. Y. H. Lip, M. Tayebjee, W. Foster, and A. D. Blann, “Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes,” Blood, vol. 105, no. 2, pp. 526–532, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Mutin, I. Canavy, A. Blann, M. Bory, J. Sampol, and F. Dignat-George, “Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells,” Blood, vol. 93, no. 9, pp. 2951–2958, 1999. View at Google Scholar · View at Scopus
  70. F. George, P. Brouqui, M.-C. Boffa et al., “Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever,” Blood, vol. 82, no. 7, pp. 2109–2116, 1993. View at Google Scholar · View at Scopus
  71. E. Percivalle, M. G. Revello, L. Vago, F. Morini, and G. Gerna, “Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement,” Journal of Clinical Investigation, vol. 92, no. 2, pp. 663–670, 1993. View at Google Scholar · View at Scopus
  72. M. Koc, H. B. Richards, A. Bihorac, E. A. Ross, J. D. Schold, and M. S. Segal, “Circulating endothelial cells are associated with future vascular events in hemodialysis patients,” Kidney International, vol. 67, no. 3, pp. 1078–1083, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. Z. Kun-Ying, L. Hui-Lan, D. Xiao-Feng, and L. Guo-Gang, “Association between circulating endothelial cells and carotid atherosclerosis in patients receiving maintenance hemodialysis,” BioMed Research International, vol. 2014, Article ID 753759, 7 pages, 2014. View at Publisher · View at Google Scholar
  74. G. Yao, Z.-H. Liu, C. Zheng et al., “Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis,” Rheumatology, vol. 47, no. 4, pp. 432–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. U. Erdbruegger, A. Woywodt, T. Kirsch, H. Haller, and M. Haubitz, “Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy,” The American Journal of Kidney Diseases, vol. 48, no. 4, pp. 564–570, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Futrakul, P. Butthep, and P. Futrakul, “Biomarkers of endothelial injury in focal segmental glomerulosclerotic nephrosis,” Renal Failure, vol. 27, no. 4, pp. 393–395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. N. Futrakul, P. Butthep, and P. Futrakul, “Altered vascular homeostasis in chronic kidney disease,” Clinical Hemorheology and Microcirculation, vol. 38, no. 3, pp. 201–207, 2008. View at Google Scholar · View at Scopus
  78. E. Rodríguez-Ayala, Q. Yao, C. Holmén, B. Lindholm, S. Sumitran-Holgersson, and P. Stenvinkel, “Imbalance between detached circulating endothelial cells and endothelial progenitor cells in chronic kidney disease,” Blood Purification, vol. 24, no. 2, pp. 196–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. A. O. Ojo, “Cardiovascular complications after renal transplantation and their prevention,” Transplantation, vol. 82, no. 5, pp. 603–611, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. E. R. Popa, A. M. Kas-Deelen, B. G. Hepkema, W. J. Van Son, T. Hauw The, and M. C. Harmsen, “Donor-derived circulating endothelial cells after kidney transplantation,” Transplantation, vol. 74, no. 9, pp. 1320–1327, 2002. View at Google Scholar · View at Scopus
  81. A. S. Mohamed, J. Thomson, K. J. McDonald et al., “Circulating endothelial cells in renal transplant recipients,” Transplantation Proceedings, vol. 37, no. 5, pp. 2387–2390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Al-Massarani, H. Vacher-Coponat, P. Paul et al., “Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation,” The American Journal of Transplantation, vol. 8, no. 11, pp. 2360–2367, 2008. View at Publisher · View at Google Scholar · View at Scopus